Search | Sngine

Shahir Shahir added blog Other
2026-03-18 13:51:54 -

Breast Cancer Diagnostics Market Expansion to USD 12.4 Billion by 2036
The global landscape for breast cancer diagnostics is undergoing a fundamental shift from volume-based testing to value-based precision diagnostics. According to the latest strategic analysis by Fact.MR, the market, valued at USD 5,878 million in 2025, is poised to reach USD 6,389.41 million in 2026. This trajectory is set to continue at a steady 6.9% CAGR, propelling the industry to a...

0 Comments 0 Shares 520 Views 0 Reviews

Please log in to like, share and comment!
Akshay Gorde added blog Health
2026-09-17 17:20:19 -

Breast Cancer Diagnostics Market Growth, Global Trends, Size, Segmentation, Opportunities, Forecast Analysis By Fact.MR
ROCKVILLE, MD /Sept 17, 2026 – According to Fact.MR estimates, the breast cancer diagnostics market stood at USD 5,878.0 million in 2025. The market is projected to reach USD 6,389.41 million in 2026 and climb to USD 12,451.97 million by 2036, progressing at a CAGR of 6.9%. Absolute dollar growth of USD 6,063 million is expected over the 2026–2036 forecast period....

0 Comments 0 Shares 182 Views 0 Reviews

Please log in to like, share and comment!
Akshay Gorde added blog Food
2026-08-20 19:48:49 -

Breast Cancer Diagnostics Market Growth, Trends, Company Profiles, Market Share Analysis By Fact.MR
Hologic Leads U.S. Adoption as Breast Cancer Diagnostics Market Rises from USD 5,878.0 million in 2025 to USD 12,451.97 million by 2036 at 6.9% CAGR ROCKVILLE, MD /August 20, 2026 – According to Fact.MR estimates, the breast cancer diagnostics market stood at USD 5,878.0 million in 2025. The market is projected to reach USD 6,389.41 million in 2026 and climb to USD...

0 Comments 0 Shares 355 Views 0 Reviews

Please log in to like, share and comment!
Akshay Gorde added blog Health
2026-04-07 12:37:11 -

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth, Overview and Forecast Analysis By FMI
NEWARK, DE / April 7, 2026 / The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million in 2025 to USD 92.92 million by 2035, registering a CAGR of 3.7%. Growth is driven by the rising prevalence of ESR1 mutations in metastatic breast cancer patients, increasing adoption of precision medicine, and advancements in...

0 Comments 0 Shares 545 Views 0 Reviews

Please log in to like, share and comment!